Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

1,108 public trials 143 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Completed

A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)

NCT00471497

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +13 more
Locations
  • University of California at Los Angeles Dept. of Hematology Clinic Los Angeles, California, United States
  • Kaiser Permanente - California Southern Dept of Kaiser South 3 San Diego, California, United States
  • Kaiser Permanente - California Northern Vallejo Med Center/Med Offices Vallejo, California, United States
  • Kaiser Permanente - California Northern Kaiser Med Vallejo, California, United States
View all 213 locations
View Trial Details
Completed

Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia

NCT02092324

Conditions
Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Bone Marrow Diseases, Chronic Disease, +14 more
Locations
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • OHSU Knight Cancer Institute Portland, Oregon, United States
View Trial Details

Related conditions